During the past decade, Azienda Ospedaliera Pediatrica Santobono Pausillipon conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Canadian Cancer Trials Group" with 2 trials sponsored, "Associazione Italiana Ematologia Oncologia Pediatrica" with 1 trials sponsored, "Bioverativ, a Sanofi company" with 1 trials sponsored and "Martin Schrappe" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" #1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" are "Acute Lymphoblastic Leukemia, Pediatric" (1 trials), "Acute Promyelocytic Leukemia" (1 trials), "Hemophilia A With Inhibitors" (1 trials), "Mesothelioma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" are "Drug" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "6-Mercaptopurine" (1 trials), "All-trans retinoic acid" (1 trials), "Antihemophilic Factor (Recombinant)" (1 trials), "Arsenic Trioxide" (1 trials) and "Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Pediatrica Santobono Pausillipon" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Pediatrica Santobono Pausillipon". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Azienda Ospedaliera Pediatrica Santobono Pausillipon, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Pediatrica Santobono Pausillipon, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Azienda Ospedaliera Pediatrica Santobono Pausillipon has several departments that took part in Clinical trials: "Unità di Chirurgia Plastica e Ustioni Ospedale Santobono" - 3 trials